Cypherpunk Technologies (FRA:5MC) Common Stock: €0.08 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:5MC Cypherpunk Technologies Inc FRA:5MC
41 GF Score
Price €0.56
! 3 Warning Signs
View Full Analysis

What is Cypherpunk Technologies Common Stock?

Cypherpunk Technologies FRA:5MC -4.11% 41 Common Stock is €0.08 Mil as of Mar. 2026. GuruFocus rates FRA:5MC with a GF Score™ of 41/100. The stock has 3 warning signs investors should review.

Cypherpunk Technologies's quarterly common stock increased from Sep. 2025 (€0.04 Mil) to Dec. 2025 (€0.07 Mil) and increased from Dec. 2025 (€0.07 Mil) to Mar. 2026 (€0.08 Mil).

Cypherpunk Technologies's annual common stock increased from Dec. 2023 (€0.02 Mil) to Dec. 2024 (€0.04 Mil) and increased from Dec. 2024 (€0.04 Mil) to Dec. 2025 (€0.07 Mil).

Cypherpunk Technologies Common Stock Historical Data

* Premium members only.

The historical data trend for Cypherpunk Technologies's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cypherpunk Technologies Common Stock Chart

Cypherpunk Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 0.09 0.02 0.04 0.07

Cypherpunk Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.04 0.04 0.07 0.08
FRA:5MC
41GF Score
Cypherpunk Technologies Inc FRA:5MC
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cypherpunk Technologies Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of €0.08 Mil mean?
Cypherpunk Technologies (FRA:5MC) has a Common Stock of €0.08 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Cypherpunk Technologies and its competitors.
Is Cypherpunk Technologies' Common Stock too high?
Cypherpunk Technologies' current Common Stock is €0.08 Mil. Overall, Cypherpunk Technologies has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Cypherpunk Technologies' Common Stock compare to VLT and PGZ?
Cypherpunk Technologies' Common Stock of €0.08 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for an Asset Management company?
A good Common Stock depends on the Asset Management industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Cypherpunk Technologies and its competitors. Cypherpunk Technologies's current Common Stock is €0.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cypherpunk Technologies stock overvalued right now?
Cypherpunk Technologies (FRA:5MC) has a current Common Stock of €0.08 Mil. The current Common Stock is €0.08 Mil. Cypherpunk Technologies' overall GF Score™ is 41/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Cypherpunk Technologies (FRA:5MC), the current Common Stock is €0.08 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cypherpunk Technologies Business Description

Other Exchanges CYPH:USA5MC:Germany
Address 47 Thorndike Street, Suite B1-1, Cambridge, MA, USA, 02141
Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.
41GF Score

Get the complete analysis for FRA:5MC

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.56
Price